Andon Health Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100000Q84
CNY
76.13
-2.17 (-2.77%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
301.48
296.28
304.05
258.27
507.00
500.14
741.15
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
301.48
296.28
304.05
258.27
507.00
500.14
741.15
Raw Material Cost
93.46
134.95
122.15
120.17
160.90
181.04
203.50
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
29.75
25.86
33.13
35.55
18.97
19.25
16.99
Selling and Distribution Expenses
155.71
145.01
185.07
250.47
230.44
230.31
232.81
Other Expenses
2.27
7.08
2.15
3.94
6.61
6.11
3.94
Total Expenditure (Excl Depreciation)
301.63
376.61
361.87
445.63
476.38
491.70
492.72
Operating Profit (PBDIT) excl Other Income
-0.1
-80.3
-57.800000000000004
-187.39999999999998
30.6
8.4
248.4
Other Income
116.23
197.26
192.20
233.73
237.07
203.38
218.19
Operating Profit (PBDIT)
115.45
116.06
151.16
55.63
286.44
176.13
479.51
Interest
29.75
25.86
33.13
35.55
18.97
19.25
16.99
Exceptional Items
300.16
862.18
517.75
677.52
56.09
146.18
525.75
Gross Profit (PBDT)
208.02
161.33
181.89
138.09
346.10
319.09
537.65
Depreciation
0.00
20.51
20.51
20.06
20.06
13.32
13.32
Profit Before Tax
385.86
931.86
615.26
677.54
303.50
289.74
974.95
Tax
81.40
249.21
-52.32
35.18
25.69
23.27
142.39
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
293.53
677.68
668.89
653.89
266.28
300.09
766.88
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
293.53
677.68
668.89
653.89
266.28
300.09
766.88
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
10.92
4.06
-1.31
-11.53
11.53
-33.62
65.67
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
304.46
681.75
667.58
642.36
277.82
266.47
832.56
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
21,617.48
21,832.16
22,189.23
21,774.41
21,421.90
20,736.50
19,272.90
Earnings per share (EPS)
0.69
1.57
1.63
1.5
0.6
0.68
1.79
Diluted Earnings per share
0.69
1.57
1.63
1.5
0.6
0.68
1.79
Operating Profit Margin (Excl OI)
-0.26%
-34.33%
-20.24%
-76.73%
5.78%
-8.11%
33.46%
Gross Profit Margin
127.99%
321.45%
209.1%
270.11%
63.82%
60.6%
133.34%
PAT Margin
97.36%
228.73%
220.0%
253.18%
52.52%
60.0%
103.47%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2026 is 1.75% vs -2.53% in Dec 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is -55.33% vs 2.11% in Dec 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is 99.01% vs -98.05% in Dec 2025

stock-summary

Interest

QoQ Growth in quarter ended Mar 2026 is 14.67% vs -21.75% in Dec 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

Compare Quarterly Results Of Andon Health Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
301.48
0
301.48
Other Operating Income
0.00
0.00
0.00
Total Operating income
301.48
0
301.48
Raw Material Cost
93.46
0
93.46
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
29.75
0
29.75
Selling and Distribution Expenses
155.71
0
155.71
Other Expenses
2.27
0.00
2.27
Total Expenditure (Excl Depreciation)
301.63
0
301.63
Operating Profit (PBDIT) excl Other Income
-0.14
0.00
-0.14
Other Income
116.23
0
116.23
Operating Profit (PBDIT)
115.45
0
115.45
Interest
29.75
0
29.75
Exceptional Items
300.16
0
300.16
Gross Profit (PBDT)
208.02
0
208.02
Depreciation
0.00
0
0.00
Profit Before Tax
385.86
0
385.86
Tax
81.40
0
81.40
Provisions and contingencies
0
0
0.00
Profit After Tax
293.53
0
293.53
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
293.53
0
293.53
Share in Profit of Associates
0
0
0.00
Minority Interest
10.92
0
10.92
Other related items
0.00
0.00
0.00
Consolidated Net Profit
304.46
0
304.46
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
21,617.48
0
21,617.48
Earnings per share (EPS)
0.69
0
0.69
Diluted Earnings per share
0.69
0
0.69
Operating Profit Margin (Excl OI)
-0.26%
0%
0.00
-0.26%
Gross Profit Margin
127.99%
0%
0.00
127.99%
PAT Margin
97.36%
0%
0.00
97.36%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 30.15 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 1.75% vs -2.53% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -40.53% vs -33.49% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 30.45 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -55.33% vs 2.11% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 9.61% vs -10.53% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) -0.08 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 99.01% vs -98.05% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -101.62% vs -84.29% in Mar 2025

Quarterly - Interest
Interest 2.97 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 14.67% vs -21.75% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 56.32% vs 71.17% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -0.26%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025